Matthew Walsh
Directeur Financier/CFO chez ORGANON & CO.
Fortune : 5 M $ au 30/04/2024
Profil
Matthew M. Walsh occupe le poste de directeur financier chez Organon & Co. et celui de directeur et vice-président chez Topokine Therapeutics, Inc. Il est également membre du conseil d'administration de Certara USA, Inc. et de Certara, Inc. Auparavant, M. Walsh était président, directeur général et directeur financier de Spectrum Group International, Inc. et directeur financier, trésorier et contrôleur de GenTek, Inc. et directeur financier et vice-président exécutif de Catalent, Inc. et directeur financier et vice-président exécutif de Catalent Pharma Solutions, Inc. (une filiale de Catalent, Inc.), directeur financier et vice-président exécutif d'Allergan Ltd. (Irlande) et directeur financier, directeur et vice-président exécutif d'Allergan GI Corp. Matthew M. Walsh a obtenu un diplôme de premier cycle à l'université Cornell et un MBA à la Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERTARA, INC.
0,11% | 28/03/2024 | 176 968 ( 0,11% ) | 3 M $ | 30/04/2024 |
ORGANON & CO.
0,03% | 04/05/2024 | 88 326 ( 0,03% ) | 2 M $ | 30/04/2024 |
Postes actifs de Matthew Walsh
| Sociétés | Poste | Début |
|---|---|---|
| CERTARA, INC. | Directeur/Membre du Conseil | 01/08/2017 |
| ORGANON & CO. | Directeur Financier/CFO | 02/06/2021 |
Topokine Therapeutics, Inc.
 Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Directeur/Membre du Conseil | - |
Certara USA, Inc.
 Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Directeur/Membre du Conseil | 26/08/2020 |
Certara Holdings, Inc.
 Certara Holdings, Inc. Packaged SoftwareTechnology Services Part of Certara, Inc., Certara Holdings, Inc. develops software for clinical pharmacology. The company is based in Princeton, NJ. William F. Feehery has been the CEO of the company since 2019. | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Walsh
| Sociétés | Poste | Fin |
|---|---|---|
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Directeur Financier/CFO | 01/06/2020 |
| ALLERGAN PLC | Directeur Financier/CFO | 08/05/2020 |
| ALLERGAN, INC. | Directeur Financier/CFO | 01/01/2020 |
| CATALENT, INC. | Directeur Financier/CFO | 01/01/2018 |
| ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Matthew Walsh
| Cornell University | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SPECTRUM GROUP INTERNATIONAL, INC. | Retail Trade |
| CATALENT, INC. | Health Technology |
| CERTARA, INC. | Technology Services |
| ORGANON & CO. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
GenTek, Inc.
 GenTek, Inc. Chemicals: SpecialtyProcess Industries GenTek, Inc. manufactures industrial components and performance chemicals. It offers ground and flight instrumentation, complete environmental testing, industrial and process control, satellite tracking and control, and aircraft structural testing. The company was founded in 1994 and is headquartered in Tampa, FL. | Process Industries |
Multi-Color Corp.
 Multi-Color Corp. Commercial Printing/FormsCommercial Services Multi-Color Corp. engages in the provision of label solutions supporting. Its products include pressure sensitive labels, in-mold labels, heat transfer labels, glue-applied labels, shrink sleeve labels, and graphic services. The company was founded in 1916 and is headquartered in Batavia, OH. | Commercial Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
Topokine Therapeutics, Inc.
Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Health Technology |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | Commercial Services |
Certara Holdings, Inc.
Certara Holdings, Inc. Packaged SoftwareTechnology Services Part of Certara, Inc., Certara Holdings, Inc. develops software for clinical pharmacology. The company is based in Princeton, NJ. William F. Feehery has been the CEO of the company since 2019. | Technology Services |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
